{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:41:15Z","timestamp":1788352875443,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei","doi-asserted-by":"crossref","award":["No. 2018CFB289"],"award-info":[{"award-number":["No. 2018CFB289"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science Foundation of Health Commission of Hubei Province","award":["No. WJ2019M074"],"award-info":[{"award-number":["No. WJ2019M074"]}]},{"name":"the Science and Technology Planning Project of Jingmen","award":["No. 2020YFZD022"],"award-info":[{"award-number":["No. 2020YFZD022"]}]},{"name":"the Project of Administration of Traditional Chinese Medicine of Guangdong Province of China","award":["No. 20221280"],"award-info":[{"award-number":["No. 20221280"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03346-0","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:39:07Z","timestamp":1762958347000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Single-cell RNA sequencing and in vitro validation reveal risankizumab induces anti-inflammatory macrophage polarization in psoriasis"],"prefix":"10.1186","volume":"30","author":[{"given":"Yuan","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linzi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"3346_CR1","doi-asserted-by":"crossref","unstructured":"Sharma K, Kumar S. Current strategies for the management of psoriasis with potential pharmacological pathways using herbals and immuno-biologicals. Curr Mole Pharmacol. 2024;17.","DOI":"10.2174\/1874467217666230915125613"},{"issue":"2","key":"3346_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/all.15486","volume":"78","author":"B Zhang","year":"2023","unstructured":"Zhang B, Roesner LM, Traidl S, Koeken V, Xu CJ, Werfel T, et al. Single-cell profiles reveal distinctive immune response in atopic dermatitis in contrast to psoriasis. Allergy. 2023;78(2):439\u201353.","journal-title":"Allergy"},{"issue":"3","key":"3346_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/00325481.2020.1831315","volume":"133","author":"JJ Crowley","year":"2021","unstructured":"Crowley JJ, Pariser DM, Yamauchi PS. A brief guide to pustular psoriasis for primary care providers. Postgrad Med. 2021;133(3):330\u201344.","journal-title":"Postgrad Med"},{"issue":"9583","key":"3346_CR4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CE Griffiths","year":"2007","unstructured":"Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet. 2007;370(9583):263\u201371.","journal-title":"Lancet"},{"key":"3346_CR5","doi-asserted-by":"crossref","unstructured":"Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Annals of the rheumatic diseases. 2005;64 Suppl 2(Suppl 2):ii18\u201323; discussion ii4\u20135.","DOI":"10.1136\/ard.2004.033217"},{"issue":"5","key":"3346_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1177\/2040622318759282","volume":"9","author":"TC Chan","year":"2018","unstructured":"Chan TC, Hawkes JE, Krueger JG. Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment. Ther Adv Chronic Dis. 2018;9(5):111\u20139.","journal-title":"Ther Adv Chronic Dis"},{"issue":"9","key":"3346_CR7","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1111\/jdv.15653","volume":"33","author":"JJ Crowley","year":"2019","unstructured":"Crowley JJ, Warren RB, Cather JC. Safety of selective IL-23p19 inhibitors for the treatment of psoriasis. J Euro Acad Dermatol Venereol JEADV. 2019;33(9):1676\u201384.","journal-title":"J Euro Acad Dermatol Venereol JEADV"},{"issue":"1","key":"3346_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-015-0539-8","volume":"38","author":"SK Mahil","year":"2016","unstructured":"Mahil SK, Capon F, Barker JN. Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 2016;38(1):11\u201327.","journal-title":"Semin Immunopathol"},{"issue":"11","key":"3346_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079253","volume":"8","author":"WR Swindell","year":"2013","unstructured":"Swindell WR, Johnston A, Xing X, Voorhees JJ, Elder JT, Gudjonsson JE. Modulation of epidermal transcription circuits in psoriasis: new links between inflammation and hyperproliferation. PLoS ONE. 2013;8(11):e79253.","journal-title":"PLoS ONE"},{"issue":"5","key":"3346_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1155\/MI.2005.273","volume":"2005","author":"O Arican","year":"2005","unstructured":"Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005;2005(5):273\u20139.","journal-title":"Mediators Inflamm"},{"issue":"3","key":"3346_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita J, Grewal S, Langan SM, Mehta NN, Ogdie A, Van Voorhees AS, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377\u201390.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3346_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/09546634.2014.880396","volume":"26","author":"G Girolomoni","year":"2015","unstructured":"Girolomoni G, Griffiths CE, Krueger J, Nestle FO, Nicolas JF, Prinz JC, et al. Early intervention in psoriasis and immune-mediated inflammatory diseases: a hypothesis paper. J Dermatolog Treat. 2015;26(2):103\u201312.","journal-title":"J Dermatolog Treat"},{"issue":"10340","key":"3346_CR13","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S0140-6736(22)00467-6","volume":"399","author":"G D'Haens","year":"2022","unstructured":"D\u2019Haens G, Panaccione R, Baert F, Bossuyt P, Colombel JF, Danese S, et al. Risankizumab as induction therapy for Crohn\u2019s disease: results from the phase 3 advance and motivate induction trials. Lancet. 2022;399(10340):2015\u201330.","journal-title":"Lancet"},{"issue":"1","key":"3346_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1346-8138.16583","volume":"50","author":"K Kamiya","year":"2023","unstructured":"Kamiya K, Ohtsuki M. Epidemiological survey of patients with pustular psoriasis in the Japanese Society for Psoriasis Research from 2017 to 2020. J Dermatol. 2023;50(1):3\u201311.","journal-title":"J Dermatol"},{"issue":"9","key":"3346_CR15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","volume":"77","author":"D Baeten","year":"2018","unstructured":"Baeten D, \u00d8stergaard M, Wei JC, Sieper J, J\u00e4rvinen P, Tam LS, et al. Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Ann Rheum Dis. 2018;77(9):1295\u2013302.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"3346_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S2468-1253(18)30233-4","volume":"3","author":"BG Feagan","year":"2018","unstructured":"Feagan BG, Pan\u00e9s J, Ferrante M, Kaser A, D\u2019Haens GR, Sandborn WJ, et al. Risankizumab in patients with moderate to severe Crohn\u2019s disease: an open-label extension study. Lancet Gastroenterol Hepatol. 2018;3(10):671\u201380.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"3346_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jaci.2015.01.018","volume":"136","author":"JG Krueger","year":"2015","unstructured":"Krueger JG, Ferris LK, Menter A, Wagner F, White A, Visvanathan S, et al. Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2015;136(1):116-24.e7.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3346_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/s41467-024-44994-w","volume":"15","author":"L Francis","year":"2024","unstructured":"Francis L, McCluskey D, Ganier C, Jiang T, Du-Harpur X, Gabriel J, et al. Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade. Nat Commun. 2024;15(1):913.","journal-title":"Nat Commun"},{"key":"3346_CR19","doi-asserted-by":"crossref","unstructured":"Shahrajabian MH, Sun W. Survey on Multi-omics, and Multi-omics Data Analysis, Integration and Application. Current Pharmaceutical Analysis. 2023;19(4):267\u201381.","DOI":"10.2174\/1573412919666230406100948"},{"issue":"6","key":"3346_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.32604\/chd.2023.047689","volume":"18","author":"A Zulibiya","year":"2023","unstructured":"Zulibiya A, Wen J, Yu H, Chen X, Xu L, Ma X, et al. Single-cell RNA sequencing reveals potential for endothelial-to-mesenchymal transition in Tetralogy of Fallot. Congenit Heart Dis. 2023;18(6):611\u201325.","journal-title":"Congenit Heart Dis"},{"issue":"6","key":"3346_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.32604\/chd.2024.048081","volume":"18","author":"Z Song","year":"2023","unstructured":"Song Z, Yu J, Wang M, Shen W, Wang C, Lu T, et al. CHDTEPDB: transcriptome expression profile database and interactive analysis platform for Congenital Heart Disease. Congenit Heart Dis. 2023;18(6):693\u2013701.","journal-title":"Congenit Heart Dis"},{"issue":"D1","key":"3346_CR22","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"key":"3346_CR23","doi-asserted-by":"publisher","first-page":"1335333","DOI":"10.3389\/fimmu.2024.1335333","volume":"15","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Yu W, Hu T, Peng H, Hu F, Yuan Y, et al. Unveiling macrophage diversity in myocardial ischemia-reperfusion injury: identification of a distinct lipid-associated macrophage subset. Front Immunol. 2024;15:1335333.","journal-title":"Front Immunol"},{"key":"3346_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-3155-9-13","volume":"9","author":"M Nowostawska","year":"2011","unstructured":"Nowostawska M, Corr SA, Byrne SJ, Conroy J, Volkov Y, Gun\u2019ko YK. Porphyrin-magnetite nanoconjugates for biological imaging. J Nanobiotechnology. 2011;9:13.","journal-title":"J Nanobiotechnology"},{"issue":"7","key":"3346_CR25","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1158\/2326-6066.CIR-22-0814","volume":"11","author":"W Liang","year":"2023","unstructured":"Liang W, Liu H, Zeng Z, Liang Z, Xie H, Li W, et al. KRT17 promotes T-lymphocyte infiltration through the YTHDF2-CXCL10 axis in colorectal cancer. Cancer Immunol Res. 2023;11(7):875\u201394.","journal-title":"Cancer Immunol Res"},{"key":"3346_CR26","doi-asserted-by":"crossref","unstructured":"Qiu J, Zhou T, Wang D, Hong W, Qian D, Meng X, et al. Pan-cancer analysis identifies AIMP2 as a potential biomarker for breast cancer. Curr Genom. 2023;24(5):307\u201329.","DOI":"10.2174\/0113892029255941231014142050"},{"issue":"4","key":"3346_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.2174\/0115665232308789240823052607","volume":"25","author":"S-L Lin","year":"2025","unstructured":"Lin S-L, Lee S-T, Huang S-E, Chang T-H, Geng Y-J, Sulistyowati E, et al. Delivery of superoxide dismutase 3 gene with baculoviruses inhibits TNF-\u03b1 triggers vascular smooth muscle cell proliferation and inflammation. Curr Gene Ther. 2025;25(4):546\u201358.","journal-title":"Curr Gene Ther"},{"issue":"2","key":"3346_CR28","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/jid.2010.280","volume":"131","author":"M Su\u00e1rez-Fari\u00f1as","year":"2011","unstructured":"Su\u00e1rez-Fari\u00f1as M, Fuentes-Duculan J, Lowes MA, Krueger JG. Resolved psoriasis lesions retain expression of a subset of disease-related genes. J Invest Dermatol. 2011;131(2):391\u2013400.","journal-title":"J Invest Dermatol"},{"key":"3346_CR29","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3389\/fimmu.2018.01682","volume":"9","author":"NC Brembilla","year":"2018","unstructured":"Brembilla NC, Senra L, Boehncke WH. The IL-17 family of cytokines in psoriasis: IL-17A and beyond. Front Immunol. 2018;9:1682.","journal-title":"Front Immunol"},{"issue":"3","key":"3346_CR30","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ccell.2023.02.009","volume":"41","author":"L van Vlerken-Ysla","year":"2023","unstructured":"van Vlerken-Ysla L, Tyurina YY, Kagan VE, Gabrilovich DI. Functional states of myeloid cells in cancer. Cancer Cell. 2023;41(3):490\u2013504.","journal-title":"Cancer Cell"},{"issue":"3","key":"3346_CR31","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/jid.2013.404","volume":"134","author":"AL Croxford","year":"2014","unstructured":"Croxford AL, Karbach S, Kurschus FC, W\u00f6rtge S, Nikolaev A, Yogev N, et al. IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions. J Invest Dermatol. 2014;134(3):728\u201335.","journal-title":"J Invest Dermatol"},{"key":"3346_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18122514","author":"K Boche\u0144ska","year":"2017","unstructured":"Boche\u0144ska K, Smoli\u0144ska E, Moskot M, Jak\u00f3bkiewicz-Banecka J, Gabig-Cimi\u0144ska M. Models in the research process of Psoriasis. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18122514.","journal-title":"Int J Mol Sci"},{"key":"3346_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102427","volume":"55","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li Y, Zhou L, Yuan X, Wang Y, Deng Q, et al. Nav1.8 in keratinocytes contributes to ROS-mediated inflammation in inflammatory skin diseases. Redox Biol. 2022;55:102427.","journal-title":"Redox Biol"},{"issue":"9","key":"3346_CR34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1001\/archdermatol.2011.119","volume":"147","author":"NN Mehta","year":"2011","unstructured":"Mehta NN, Yu Y, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, et al. Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET\/CT): a pilot study. Arch Dermatol. 2011;147(9):1031\u20139.","journal-title":"Arch Dermatol"},{"issue":"3","key":"3346_CR35","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jid.2018.09.021","volume":"139","author":"R Sch\u00fcler","year":"2019","unstructured":"Sch\u00fcler R, Brand A, Klebow S, Wild J, Veras FP, Ullmann E, et al. Antagonization of IL-17A attenuates skin inflammation and vascular dysfunction in mouse models of psoriasis. J Invest Dermatol. 2019;139(3):638\u201347.","journal-title":"J Invest Dermatol"},{"issue":"10148","key":"3346_CR36","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/S0140-6736(18)31781-1","volume":"392","author":"A Cline","year":"2018","unstructured":"Cline A, Feldman SR. Risankizumab for psoriasis. Lancet (London, England). 2018;392(10148):616\u20137.","journal-title":"Lancet (London, England)"},{"key":"3346_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/978-1-4939-7837-3_12","volume":"1784","author":"X Huang","year":"2018","unstructured":"Huang X, Li Y, Fu M, Xin HB. Polarizing Macrophages In Vitro. Methods Mole Biol (Clifton, NJ). 2018;1784:119\u201326.","journal-title":"Methods Mole Biol (Clifton, NJ)"},{"issue":"1","key":"3346_CR38","doi-asserted-by":"publisher","first-page":"147","DOI":"10.32604\/oncologie.2022.019236","volume":"24","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Wang Y, Zou C, Hu B, Zhao M, Wu X. Tumor-associated macrophages facilitate the proliferation and migration of cervical cancer cells. Oncologie. 2022;24(1):147\u201361.","journal-title":"Oncologie"},{"issue":"10","key":"3346_CR39","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889\u201396.","journal-title":"Nat Immunol"},{"issue":"1","key":"3346_CR40","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jdermsci.2012.07.007","volume":"68","author":"M Sugaya","year":"2012","unstructured":"Sugaya M, Miyagaki T, Ohmatsu H, Suga H, Kai H, Kamata M, et al. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma. J Dermatol Sci. 2012;68(1):45\u201351.","journal-title":"J Dermatol Sci"},{"issue":"11","key":"3346_CR41","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/jcmm.17748","volume":"27","author":"JH Huang","year":"2023","unstructured":"Huang JH, Lin YL, Wang LC, Chiang BL. M2-like macrophages polarized by Foxp3(-) treg-of-B cells ameliorate imiquimod-induced psoriasis. J Cell Mol Med. 2023;27(11):1477\u201392.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"3346_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s40265-024-02028-1","volume":"84","author":"SE Thomas","year":"2024","unstructured":"Thomas SE, Barenbrug L, Hannink G, Seyger MMB, de Jong E, van den Reek J. Drug survival of IL-17 and IL-23 inhibitors for psoriasis: a systematic review and meta-analysis. Drugs. 2024;84(5):565\u201378.","journal-title":"Drugs"},{"issue":"1","key":"3346_CR43","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2021.1964420","volume":"13","author":"L Zhou","year":"2021","unstructured":"Zhou L, Wang Y, Wan Q, Wu F, Barbon J, Dunstan R, et al. A non-clinical comparative study of IL-23 antibodies in psoriasis. MAbs. 2021;13(1):1964420.","journal-title":"MAbs"},{"key":"3346_CR44","doi-asserted-by":"publisher","first-page":"1532852","DOI":"10.3389\/fimmu.2025.1532852","volume":"16","author":"KL Sachen","year":"2025","unstructured":"Sachen KL, Hammaker D, Sarabia I, Stoveken B, Hartman J, Leppard KL, et al. Guselkumab binding to CD64(+) IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling. Front Immunol. 2025;16:1532852.","journal-title":"Front Immunol"},{"key":"3346_CR45","doi-asserted-by":"publisher","first-page":"1331217","DOI":"10.3389\/fimmu.2024.1331217","volume":"15","author":"JG Krueger","year":"2024","unstructured":"Krueger JG, Eyerich K, Kuchroo VK, Ritchlin CT, Abreu MT, Elloso MM, et al. IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy. Front Immunol. 2024;15:1331217.","journal-title":"Front Immunol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03346-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03346-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:39:11Z","timestamp":1762958351000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03346-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3346"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03346-0","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1114"}}